Second, we used the ELISA method to assess the secretion of CCL2, a vascular damage marker, and discovered that CCL2 expression was raised in HUVECs treated with hyperglycemia and senescence, while high glucose increased CCL2 expression in aging HUVECs (Figure 3A,C). The gene discussed is CCL2; the disease is Hyperglycemia.